Bağ Doku Hastalıkları ve D Vitamini
Özet
Bu yazı, D vitamininin immün sistem modülasyonu ve antiinflamatuar özellikleri doğrultusunda bağ dokusu hastalıkları (BDH) ile olan ilişkisini incelemektedir. Yağda çözünen ve aktif metaboliti 1,25 dihidroksi vitamin D olan bu vitaminin reseptörleri (VDR); antijen sunan hücreler, monositler, T ve B hücreleri gibi çeşitli immün hücrelerde bulunur. D vitamini eksikliğinin Crohn, Graves, romatoid artrit ve sistemik lupus eritematozus (SLE) gibi birçok otoimmün hastalıkla ilişkili olduğu gösterilmiştir. Undifferansiye bağ dokusu hastalığında (UBDH) D vitamini yetersizliği, belirgin bir BDH formuna dönüşüm riskini artırmakta ve dermatolojik semptomlarla ilişkilendirilmektedir. SLE hastalarında genel popülasyona kıyasla D vitamini seviyeleri belirgin şekilde düşük bulunmuş olup, güneşten kaçınma ve kullanılan bazı ilaçlar bu düşüklüğü tetiklemektedir. Sistemik Sklerozda (SSc) ise D vitamininin antifibrotik etkileri öne çıkmakta, eksikliğinin cilt kalınlaşması, dijital ülser riski ve akciğer tutulumu ile ilişkili olabileceği bildirilmektedir. Sjögren Sendromunda (SS) B hücre aktivasyonu üzerindeki etkileri nedeniyle rol oynayabileceği düşünülse de literatürdeki sonuçlar çelişkilidir. D vitamini takviyesinin bu hastalıklardaki klinik etkinliğini ve kesin patojenik rolünü ortaya koymak adına daha fazla randomize kontrollü çalışmaya ihtiyaç duyulmaktadır.
This text examines the relationship between vitamin D and connective tissue diseases (CTD) in line with its immune system modulation and anti-inflammatory properties. The receptors (VDR) of this fat-soluble vitamin, whose active metabolite is 1,25-dihydroxyvitamin D, are found in various immune cells such as antigen-presenting cells, monocytes, T, and B cells. Vitamin D deficiency has been shown to be associated with many autoimmune diseases, including Crohn's, Graves', rheumatoid arthritis, and systemic lupus erythematosus (SLE). In undifferentiated connective tissue disease (UCTD), vitamin D insufficiency increases the risk of evolution into a well-defined CTD form and is linked to dermatological symptoms. Vitamin D levels are significantly lower in SLE patients compared to the general population, with sun avoidance and certain medications triggering this deficiency. In Systemic Sclerosis (SSc), the antifibrotic effects of vitamin D come to the fore, and its deficiency is reported to be associated with skin thickening, digital ulcer risk, and lung involvement. Although it is thought to play a role in Sjögren's Syndrome (SS) due to its effects on B-cell activation, literature results remain contradictory. More randomized controlled trials are required to establish the definitive pathogenic role and clinical efficacy of vitamin D supplementation in these diseases.
Referanslar
Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004;229(11):1136-42.
Mazzaferro S, Pasquali M. Vitamin D: a dynamic molecule. How relevant might the dynamism for a vitamin be? Nephrol Dial Transplant. 2016;31(1):23-30.
Christakos S, Dhawan P, Verstuyf A, et al. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016;96(1):365-408.
Chun RF, Liu PT, Modlin RL, et al. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol. 2014;5:151.
Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys. 2012;523(1):123-33.
Lee SM, Meyer MB, Benkusky NA, et al. The impact of VDR expression and regulation in vivo. J Steroid Biochem Mol Biol. 2018;177:36-45.
Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J. 2001;15(14):2579-85.
Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502-21.
Baeke F, Takiishi T, Korf H, et al. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482-96.
Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179(3):1634-47.
Prietl B, Pilz S, Wolf M, et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J. 2010;12(3):136-9.
Cutolo M, Paolino S, Sulli A, et al. Vitamin D, steroid hormones, and autoimmunity. Ann N Y Acad Sci. 2014;1317:39-46.
Goswami R, Marwaha RK, Gupta N, et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr. 2009;102(3):382-6.
Beretich BD, Beretich TM. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult Scler. 2009;15(8):891-8.
Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol. 2008;20(5):532-7.
Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12(2):127-36.
Narbutt J, Hołdrowicz A, Lesiak A. Morphea - selected local treatment methods and their effectiveness. Reumatologia. 2017;55(6):305-13.
Franco AS, Freitas TQ, Bernardo WM, Pereira RMR. Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(23):e7024.
Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol. 2007;21(6):1011-23.
Bodolay E, Csiki Z, Szekanecz Z, et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol. 2003;21(3):313-20.
Zold E, Szodoray P, Gaal J, et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther. 2008;10(5):R123.
Zold E, Szodoray P, Kappelmayer J, et al. Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease. Scand J Rheumatol. 2010;39(6):490-7.
D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet. 2007;369(9561):587-96.
Munoz LE, Gaipl US, Franz S, et al. SLE--a disease of clearance deficiency? Rheumatology (Oxford). 2005;44(9):1101-7.
Kamen DL, Aranow C. The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 2008;10(4):273-80.
Kamen DL, Cooper GS, Bouali H, et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006;5(2):114-7.
Damanhouri LH. Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J. 2009;30(10):1291-5.
Toloza SM, Cole DE, Gladman DD, et al. Vitamin D insufficiency in a large female SLE cohort. Lupus. 2010;19(1):13-9.
Cutillas-Marco E, Morales-Suarez-Varela M, Marquina-Vila A, Grant W. Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus. 2010;19(7):810-4.
Huisman AM, White KP, Algra A, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol. 2001;28(11):2535-9.
Singh A, Kamen DL. Potential benefits of vitamin D for patients with systemic lupus erythematosus. Dermatoendocrinol. 2012;4(2):146-51.
Mok CC. Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin Immunol. 2013;9(5):453-63.
Al-Kushi AG, Azzeh FS, Header EA, et al. Effect of Vitamin D and Calcium Supplementation in Patients with Systemic Lupus Erythematosus. Saudi J Med Med Sci. 2018;6(3):137-42.
Pakpoor J, Pakpoor J. Vitamin D deficiency and systemic lupus erythematosus: cause or consequence? Oman Med J. 2013;28(4):295.
Amital H, Szekanecz Z, Szucs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis. 2010;69(6):1155-7.
Mok CC, Birmingham DJ, Leung HW, et al. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford). 2012;51(4):644-52.
Dutta C, Kakati S, Barman B, Bora K. Vitamin D status and its relationship with systemic lupus erythematosus as a determinant and outcome of disease activity. Horm Mol Biol Clin Investig. 2019;38(3).
Ruiz-Irastorza G, Gordo S, Olivares N, et al. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken). 2010;62(8):1160-5.
Kim HA, Sung JM, Jeon JY, et al. Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol Int. 2011;31(9):1189-94.
Fragoso TS, Dantas AT, Marques CD, et al. 25-Hydroxyivitamin D3 levels in patients with systemic lupus erythematosus and its association with clinical parameters and laboratory tests. Rev Bras Reumatol. 2012;52(1):60-5.
Ruiz-Irastorza G, Egurbide MV, Olivares N, et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford). 2008;47(6):920-3.
Borba VZ, Vieira JG, Kasamatsu T, et al. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int. 2009;20(3):427-33.
Reynolds JA, Haque S, Berry JL, et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012;51(3):544-51.
Lertratanakul A, Wu P, Dyer A, et al. 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care Res (Hoboken). 2014;66(8):1167-76.
Sabio JM, Vargas-Hitos JA, Martinez-Bordonado J, et al. Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus. Lupus. 2015;24(2):155-63.
Chen FH, Liu T, Xu L, et al. Association of Serum Vitamin D Level and Carotid Atherosclerosis: A Systematic Review and Meta-analysis. J Ultrasound Med. 2018;37(6):1293-303.
Kiani AN, Fang H, Magder LS, Petri M. Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology (Oxford). 2013;52(11):2071-6.
Petri M, Bello KJ, Fang H, Magder LS. Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum. 2013;65(7):1865-71.
Lima GL, Paupitz J, Aikawa NE, et al. Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Care Res (Hoboken). 2016;68(1):91-8.
Andreoli L, Dall'Ara F, Piantoni S, et al. A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus. Lupus. 2015;24(4-5):499-506.
Denton CP. Systemic sclerosis: from pathogenesis to targeted therapy. Clin Exp Rheumatol. 2015;33(4 Suppl 92):S3-7.
Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40(2):78-83.
Hughes M, Herrick AL. Systemic sclerosis. Br J Hosp Med (Lond). 2019;80(9):530-6.
Zerr P, Vollath S, Palumbo-Zerr K, et al. Vitamin D receptor regulates TGF-beta signalling in systemic sclerosis. Ann Rheum Dis. 2015;74(3):e20.
Artaza JN, Norris KC. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol. 2009;200(2):207-21.
Zhang L, Duan Y, Zhang TP, et al. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study. Int J Rheum Dis. 2017;20(8):1002-8.
Gupta S, Mahajan VK, Yadav RS, et al. Evaluation of Serum Vitamin D Levels in Patients with Systemic Sclerosis and Healthy Controls: Results of a Pilot Study. Indian Dermatol Online J. 2018;9(4):250-5.
Calzolari G, Data V, Carignola R, Angeli A. Hypovitaminosis D in systemic sclerosis. J Rheumatol. 2009;36(12):2844; author reply 5.
Arnson Y, Amital H, Agmon-Levin N, et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev. 2011;10(8):490-4.
Bivona G, Agnello L, Pivetti A, et al. Association between hypovitaminosis D and systemic sclerosis: True or fake? Clin Chim Acta. 2016;458:115-9.
Vacca A, Cormier C, Piras M, et al. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol. 2009;36(9):1924-9.
Corrado A, Colia R, Mele A, et al. Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis. PLoS One. 2015;10(9):e0137912.
Caimmi C, Bertoldo E, Pozza A, et al. Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study. Int J Rheum Dis. 2019;22(6):1041-5.
Groseanu L, Bojinca V, Gudu T, et al. Low vitamin D status in systemic sclerosis and the impact on disease phenotype. Eur J Rheumatol. 2016;3(2):50-5.
Caramaschi P, Dalla Gassa A, Ruzzenente O, et al. Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol. 2010;29(12):1419-25.
Demir M, Uyan U, Keceoclu S, Demir C. The relationship between vitamin D deficiency and pulmonary hypertension. Prague Med Rep. 2013;114(3):154-61.
Atteritano M, Santoro D, Corallo G, et al. Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma. Int J Mol Sci. 2016;17(12).
An L, Sun MH, Chen F, Li JR. Vitamin D levels in systemic sclerosis patients: a meta-analysis. Drug Des Devel Ther. 2017;11:3119-25.
Bowman SJ. Primary Sjogren's syndrome. Lupus. 2018;27(1_suppl):32-5.
Mariette X, Gottenberg JE. Pathogenesis of Sjogren's syndrome and therapeutic consequences. Curr Opin Rheumatol. 2010;22(5):471-7.
Muller K, Oxholm P, Sorensen OH, et al. Abnormal vitamin D3 metabolism in patients with primary Sjogren's syndrome. Ann Rheum Dis. 1990;49(9):682-4.
Bang B, Asmussen K, Sorensen OH, Oxholm P. Reduced 25-hydroxyvitamin D levels in primary Sjogren's syndrome. Correlations to disease manifestations. Scand J Rheumatol. 1999;28(3):180-3.
Erten S, Sahin A, Altunoglu A, et al. Comparison of plasma vitamin D levels in patients with Sjogren's syndrome and healthy subjects. Int J Rheum Dis. 2015;18(1):70-5.
Sandhya P, Mahasampath G, Mashru P, et al. Vitamin D Levels and Associations in Indian Patients with Primary Sjogren's Syndrome. J Clin Diagn Res. 2017;11(9):OC33-OC6.
Baldini C, Delle Sedie A, Luciano N, et al. Vitamin D in "early" primary Sjogren's syndrome: does it play a role in influencing disease phenotypes? Rheumatol Int. 2014;34(8):1159-64.
Agmon-Levin N, Kivity S, Tzioufas AG, et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome. J Autoimmun. 2012;39(3):234-9.
Li L, Chen J, Jiang Y. The association between vitamin D level and Sjogren's syndrome: A meta-analysis. Int J Rheum Dis. 2019;22(3):532-3.
Carlberg C, Haq A. The concept of the personal vitamin D response index. J Steroid Biochem Mol Biol. 2018;175:12-7.
